← Open Payments lookup

AARON KATZENMEYER: Open Payments

NPI 1538454236 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,000 in 107 payments from 25 companies in 2025. Trend: 2023 $1,585 · 2024 $1,739 · 2025 $2,000

Food & beverage: $2,000
CompanyPaymentsAmount
ABBVIE INC.21$234
Axsome Therapeutics, Inc.7$232
AstraZeneca Pharmaceuticals LP8$179
PFIZER INC.10$174
Astellas Pharma US Inc7$163
Novo Nordisk Inc10$140
Takeda Pharmaceuticals U.S.A., Inc.6$119
SI-BONE, INC.1$95
Otsuka America Pharmaceutical, Inc.5$89
Amgen Inc.5$81

Products named: Veozah, UBRELVY, AIRSUPRA, Symbravo, NURTEC ODT, TRINTELLIX, Ozempic, Auvelity.

Industry payments across MS — which companies pay providers there.